RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: An Association Between Apolipoprotein E epsilon4 and Cognitive Function in Community-Dwelling Elders with Questionable Dementia

Korean J Biol Psychiatry 15(1):3-15 · 2008

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

130,153편 검색→1,957편 판독→34편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Apolipoprotein E epsilon4 allele and cognitive function in questionable dementia or mild cognitive impairment Apolipoprotein E epsilon4 allele and cognitive function in questionable dementia or mild cognitive impairment

출판 연도

2026: 34편342026

선별된 34편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01alzheimer disease · biomarkers18편

  1. 0.87

    Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies

    Xu Y, Gunasekaran TI, Gu Y et al. · The Lancet. Neurology · 2026

  2. 0.86

    APOE epsilon4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI

    Chu KY · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026

  3. 0.85

    Novel genetic profile linked to cognitive decline in Hispanics/Latinos

    Hrytsenko Y, Purushotham Y, Li Z et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  4. 0.81

    Motor sequence learning and learning to learn across the Alzheimer's disease continuum: Associations with biomarkers

    Ruitenberg MFL, Carmona Osorio PD, King JB et al. · Journal of Alzheimer's disease : JAD · 2026

  5. 0.78

    CSF APOE Secondary Glycosylation Predicts Cognitive Decline in Mild Cognitive Impairment

    Jiao Y, Du C, Ding Y et al. · Biomedicines · 2026

  6. 0.78

    Integration of blood-based biomarkers and genomic variants identifies individuals with mild cognitive impairment who benefit from multidomain intervention

    Kimura T, Nakamura A, Sugimoto T et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  7. 0.73

    A multivariate plasma pathology-cognition axis reveals biologically anchored residual cognitive heterogeneity across the Alzheimer's disease clinical spectrum

    Han W, Lei S, Li N et al. · Journal of Alzheimer's disease reports · 2026

  8. 0.72

    Prosocial helping behaviors attenuate accelerated cognitive decline driven by APOE epsilon4

    Han SH, Faul JD · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  9. 0.71

    Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts

    Gatz M, Mack WJ, Eid Rodriguez D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  10. 0.71

    APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health

    Tucker AE, Barber RC, Zhou Z et al. · Journal of Alzheimer's disease : JAD · 2026

  11. 0.69

    Clinical Practice Outcomes With Lecanemab for Alzheimer Disease

    Liu AJ, Moghadam AA, Alam MS et al. · Neurology open access · 2026

  12. 0.67

    Real-world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China

    Tang L, Chen X, Zhang L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  13. 0.65

    Associations of peripheral inflammation with hippocampal atrophy in Alzheimer's disease

    Xie H, Li Y, Gan R et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2026

  14. 0.63

    Bidirectional transitions between subjective cognitive decline and normal cognition and risk of mild cognitive impairment: A multistate Markov model study in NACC UDS

    Xiao Y, Zhou Z, Jin M et al. · Journal of Alzheimer's disease : JAD · 2026

  15. 0.62

    Plasma p-tau181 moderates the association between ten-year atherosclerotic cardiovascular disease risk and mild cognitive impairment - HABS-HD

    Contreras JA, Ortega NE, Jones R et al. · Frontiers in aging neuroscience · 2026

  16. 0.58

    Cognitive-behavioral phenotypes in FMR1 premutation carriers: a cross-population comparison with mild cognitive impairment

    Maltman N, Greenlee J, Mueller KD et al. · Frontiers in molecular neuroscience · 2026

  17. 0.58

    Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

    Kurz C, Taute M, Tegethoff P et al. · Aging brain · 2026

  18. 0.57

    Utility of biomarkers in prediction of future cognition in Alzheimer's disease continuum changes over time

    Ramezannezhad E, Dehghani M · Journal of Alzheimer's disease : JAD · 2026

02auc · performance11편

  1. 0.84

    Complement C4b and factor B in astrocyte-derived exosomes as novel biomarkers for amnestic mild cognitive impairment

    Li Y, Zhang M, Ying C et al. · Frontiers in aging neuroscience · 2026

  2. 0.75

    Comparative Value of Cognitive and Functional Assessments for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease: An ADNI Cohort Study

    Choe S · medRxiv : the preprint server for health sciences · 2026

  3. 0.73

    Evaluation of the NIH Toolbox Odor Identification Test in African American older adults with and without amnestic mild cognitive impairment

    Ece B, Giordani B, Goldstein F et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.67

    Stratifying heterogeneity in mild cognitive impairment: A multimodal subtype and stage inference approach

    Rodolfo CC, Vinicius SR, Francesca B et al. · Neurobiology of aging · 2026

  5. 0.66

    Multimodal prediction of MCI-to-dementia conversion over a two-year window

    Simkhada B, Liang TY, Cui X et al. · GeroScience · 2026

  6. 0.57

    Serum neuron-derived extracellular vesicle mitochondrial DNA as a potential biomarker for mild cognitive impairment due to AD

    Lin D, Luo Y, Qiu X et al. · Frontiers in aging neuroscience · 2026

  7. 0.55

    Machine learning-derived Alzheimer's disease dimensions: neuroanatomical, cognitive, clinical, functional, and genetic risk heterogeneity signatures

    Le HN, Ishrat S, Yaghooti B et al. · medRxiv : the preprint server for health sciences · 2026

  8. 0.54

    Systematic Modality Ablation of Multimodal Machine Learning for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease

    Choe S · medRxiv : the preprint server for health sciences · 2026

  9. 0.53

    Interpretable multimodal learning for integrating neuroimaging and genetic data in Alzheimer's disease

    Zhao K, Dai S, Zhang Y et al. · Frontiers in radiology · 2026

  10. 0.52

    No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer's disease neuroimaging initiative

    Warrick T, Misra M, Kataria S et al. · Frontiers in aging neuroscience · 2026

  11. 0.51

    Predicting MCI-to-Alzheimer's Conversion: A Systematic Benchmark of Classical, Machine Learning, and Deep Survival Models

    Santa NA, Daza-Santacoloma G, Serna WS · Diagnostics (Basel, Switzerland) · 2026

03white matter · mri3편

  1. 0.83

    APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer's disease spectrum: A retrospective observational study

    Kang S, Jeon S, Lee D et al. · European journal of nuclear medicine and molecular imaging · 2026

  2. 0.81

    Medial temporal atrophy and posterior cingulate structural covariance in mild cognitive impairment

    Yang X, Lyu J, Wang J et al. · The International journal of neuroscience · 2026

  3. 0.53

    Neurobiology of sleep apnea and cognitive impairment

    Sharafkhaneh A, BaHammam A · Progress in brain research · 2026

04regression · older2편

  1. 0.75

    Apolipoprotein E DNA Methylation Linked to Cognitive Decline in Postmenopausal Women With Breast Cancer

    Mewborn EK, Heinsberg LW, Cho MG et al. · Molecular genetics & genomic medicine · 2026

  2. 0.73

    Role of APOE varepsilon4 and varepsilon2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study

    Colbeth HL, Posis AIB, Rizvi BM et al. · Neurology · 2026